Iqvia (IQV) Releases FY18 Earnings Guidance

Iqvia (NYSE:IQV) updated its FY18 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of $5.35-5.60 for the period, compared to the Thomson Reuters consensus estimate of $5.34. The company issued revenue guidance of $8.45-8.65 billion, compared to the consensus revenue estimate of $8.53 billion.Iqvia also updated its Q1 guidance to $1.23-1.30 EPS.

A number of equities research analysts have issued reports on the stock. Morgan Stanley increased their target price on shares of Iqvia from $96.00 to $121.00 and gave the stock an overweight rating in a report on Thursday, November 9th. Zacks Investment Research lowered shares of Iqvia from a buy rating to a hold rating in a report on Friday, November 3rd. Barclays increased their target price on shares of Iqvia from $100.00 to $120.00 and gave the stock an overweight rating in a report on Friday, October 27th. Stifel Nicolaus upgraded shares of Iqvia from a hold rating to a buy rating and raised their price objective for the company from $92.00 to $128.00 in a report on Friday, October 27th. Finally, Mizuho set a $97.00 price objective on shares of Iqvia and gave the company a hold rating in a report on Wednesday, January 24th. Seven investment analysts have rated the stock with a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the stock. Iqvia has a consensus rating of Buy and a consensus target price of $109.71.

Shares of Iqvia (IQV) opened at $100.06 on Wednesday. Iqvia has a fifty-two week low of $75.94 and a fifty-two week high of $110.67. The firm has a market cap of $20,513.85, a price-to-earnings ratio of 22.52, a PEG ratio of 1.34 and a beta of 0.61. The company has a debt-to-equity ratio of 1.29, a current ratio of 1.22 and a quick ratio of 1.22.

In related news, insider James H. Erlinger III sold 10,000 shares of Iqvia stock in a transaction on Wednesday, December 20th. The shares were sold at an average price of $101.21, for a total transaction of $1,012,100.00. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, major shareholder Cpp Investment Board Private H sold 7,497,807 shares of Iqvia stock in a transaction on Thursday, November 30th. The stock was sold at an average price of $102.00, for a total transaction of $764,776,314.00. The disclosure for this sale can be found here. Insiders sold a total of 8,727,078 shares of company stock worth $890,124,079 over the last 90 days. Company insiders own 6.40% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This story was first published by American Banking News and is the property of of American Banking News. If you are accessing this story on another website, it was copied illegally and reposted in violation of United States and international copyright and trademark law. The correct version of this story can be accessed at https://www.americanbankingnews.com/2018/02/14/iqvia-iqv-releases-fy18-earnings-guidance.html.

About Iqvia

IQVIA Holdings Inc, formerly Quintiles IMS Holdings, Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.

Receive News & Ratings for Iqvia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Iqvia and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply